DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 12, 2014, Pages 1021-1028

  Da, M X ^a   Zhang, Y B ^b   Yao, J B ^a   Duan, Y X ^b  

^a GANSU PROVINCIAL HOSPITAL   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Methylation; S adenosylmethionine; VEGF C

Indexed keywords

S ADENOSYLMETHIONINE; VASCULOTROPIN C; ANTINEOPLASTIC AGENT; MESSENGER RNA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CARCINOGENESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; ONCOGENE; PHYSIOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELL LINE; XENOGRAFT;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE, NUDE; ONCOGENES; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; S-ADENOSYLMETHIONINE; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84922923822     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144005     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108, doi: 10.3322/canjclin.55.2.74.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90, doi: 10.3322/caac.20107.
3. Lordick F, Schumacher G, Becker-Schiebe M. Gastric cancer-still many questions to be solved. memo-Magazine Eur Med Oncol 2011; 4: 71-74, doi: 10.1007/s12254-011- 0267-2.
4. Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori N, et al. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol 2006; 11: 38-43, doi: 10.1007/s10147-005-0528-3.
5. Ding S, Li C, Lin S, Han Y, Yang Y, Zhang Y, et al. Distinct roles of VEGF-A and VEGF-C in tumour metastasis of gastric carcinoma. Oncol Rep 2007; 17: 369-375.
6. Gou HF, Chen XC, Zhu J, Jiang M, Yang Y, Cao D, et al. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications. J Exp Clin Cancer Res 2011; 30: 14, doi: 10.1186/1756-9966-30-14.
7. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007; 109: 1010-1017, doi: 10.1182/blood-2006-05- 021758.
8. Daura-Oller E, Cabre M, Montero MA, Paternain JL, Romeu A. Specific gene hypomethylation and cancer: new insights into coding region feature trends. Bioinformation 2009; 3: 340-343, doi: 10.6026/97320630003340.
9. Tomita H, Hirata A, Yamada Y, Hata K, Oyama T, Mori H, et al. Suppressive effect of global DNA hypomethylation on gastric carcinogenesis. Carcinogenesis 2010; 31: 1627- 1633, doi: 10.1093/carcin/bgq129.
10. Wang Z, Xu J, Geng X, Zhang W. Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis. Arch Med Res 2010; 41: 1-6, doi: 10.1016/j.arcmed.2009.11.001.
11. Rashid A, Issa JP. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 2004; 127: 1578-1588, doi: 10.1053/j.gastro.2004.09.007.
12. Honda T, Tamura G, Waki T, Kawata S, Terashima M, Nishizuka S, et al. Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 2004; 90: 838-843, doi: 10.1038/sj.bjc.6601600.
13. Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res 2004; 10: 2447-2451, doi: 10.1158/1078-0432.CCR-03-0107.
14. Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, Rabbani SA. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J Biol Chem 2002; 277: 41571-41579, doi: 10.1074/jbc.M201864200.
15. Pulukuri SM, Estes N, Patel J, Rao JS. Demethylationlinked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res 2007; 67: 930-939, doi: 10.1158/0008-5472.CAN-06-2892.
16. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 2005; 35: 227-234, doi: 10.1016/j.alcohol. 2005.03.011.
17. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992; 69: 905-914, doi: 10.1016/0092-8674(92)90610-O.
18. Jove M, Planavila A, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M. Palmitate induces tumor necrosis factoralpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 2006; 147: 552-561, doi: 10.1210/ en.2005-0440.
19. Lu SC, Mato JM. S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol 2008; 23 (Suppl 1): S73-S77, doi: 10.1111/j.1440-1746.2007.05289.x.
20. Ramani K, Yang H, Kuhlenkamp J, Tomasi L, Tsukamoto H, Mato JM, et al. Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation. Hepatology 2010; 51: 986-995.
21. Luka Z, Mudd SH, Wagner C. Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J Biol Chem 2009; 284: 22507-22511, doi: 10.1074/jbc.R109.019273.
22. Bale S, Ealick SE. Structural biology of S-adenosylmethionine decarboxylase. Amino Acids 2010; 38: 451-460, doi: 10.1007/s00726-009-0404-y.
23. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6: 107-116, doi: 10.1038/nrc1799.
24. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM. Reprogramming towards pluripotency requires AIDdependent DNA demethylation. Nature 2010; 463: 1042- 1047, doi: 10.1038/nature08752.
25. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010; 11: 191-203, doi: 10.1038/nrg2732.
26. Escoubet-Lozach L, Lin IL, Jensen-Pergakes K, Brady HA, Gandhi AK, Schafer PH, et al. Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism. Cancer Res 2009; 69: 7347-7356, doi: 10. 1158/0008-5472.CAN-08-4898.
27. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009; 30: 662- 670, doi: 10.1093/carcin/bgp042.
28. McCabe MT, Brandes JC, Vertino PM. Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res 2009; 15: 3927-3937, doi: 10.1158/ 1078-0432.CCR-08-2784.
29. Szyf M, Pakneshan P, Rabbani SA. DNA methylation and breast cancer. Biochem Pharmacol 2004; 68: 1187-1197, doi: 10.1016/j.bcp.2004.04.030.
30. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 2010; 6: e1000917, doi: 10.1371/journal.pgen.1000917.
31. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009; 30: 1889-1897, doi: 10.1093/carcin/bgp143.
32. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, et al. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 2009; 4: e4941, doi: 10.1371/journal.pone.0004941.
33. Matsumura S, Oue N, Mitani Y, Kitadai Y, Yasui W. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer 2007; 120: 1689-1695, doi: 10.1002/ijc.22433.
34. Da MX, Wu XT, Wang J, Guo TK, Zhao ZG, Luo T, et al. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res 2008; 39: 92-99, doi: 10.1016/j.arcmed.2007.06.021.
35. Liu L, Ma XL, Xiao ZL, Li M, Cheng SH, Wei YQ. Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev 2012; 13: 3089-3097, doi: 10.7314/APJCP.2012.13.7.3089.
36. He W, Tang B, Yang D, Li Y, Song W, Cheang T, et al. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients. World J Surg Oncol 2013; 11: 161, doi: 10.1186/1477-7819-11-161.
37. Guo B, Zhang Y, Luo G, Li L, Zhang J. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Anat Rec 2009; 292: 633-639, doi: 10.1002/ar.20893.
38. Zhu P, Zhang J, Chen Q, Wang J, Wang Y. Expression of vascular endothelial growth factor-C in gastric carcinoma and the effect of its antisense gene transfection on the proliferation of human gastric cancer cell line SGC-7901. Am J Surg 2012; 204: 78-83, doi: 10.1016/j.amjsurg. 2011.06.056.
39. Yao J, Da M, Guo T, Duan Y, Zhang Y. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice. Tumour Biol 2013; 34: 1493-1501, doi: 10.1007/s13277-013-0674-6.
40. Luo J, Li YN, Wang F, Zhang WM, Geng X. S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. Int J Biol Sci 2010; 6: 784- 795, doi: 10.7150/ijbs.6.784.